Enhancement of Angiogenesis by Ultrasound-Targeted Microbubble Destruction Combined with Nuclear Localization Signaling Peptides in Canine Myocardial Infarction
Table 1
Cardiac function in each group 28 days after treatment .
Groups
LVEDD (mm)
LVESD (mm)
LVEDV (ml)
LVESV (ml)
LVEF (%)
Baseline
28 d
Baseline
28 d
Baseline
28 d
Baseline
28 d
Baseline
28 d
Group A
27.1 ±
29.3 ±
25.3 ± 1.7
29.6 ± 9.4
33.2 ±
18.4 ± 5.7
23.1 ± 4.1
38.0 ± 2.4
29.7 ±
Group B
28.9 ± 1.2
31.0 ±
24.0 ± 1.2
24.7 ±
32.0 ± 3.2
37.6 ±
20.0 ± 2.3
22.0 ±
37.6 ± 2.6
41.6 ±
Group C
30.9 ±
33.4 ±
25.3 ± 1.7
26.0 ±
37.3 ± 4.5
45.0 ±
23.1 ± 3.9
23.6 ±
37.3 ± 3.1
46.9 ±
Group D
28.3 ±
29.3 ±
23.6 ± 1.7
23.7 ±
30.7 ± 6.3
33.4 ±
19.3 ± 3.8
19.9 ±
36.8 ± 3.6
40.4 ±
Group E
29.9 ±
31.0 ±
24.9 ± 1.9
26.6 ±
34.9 ± 6.2
37.8 ±
22.0 ± 4.1
26.1 ±
36.9 ± 3.1
33.6 ±
2.959
5.040
2.600
4.065
1.66
4.932
1.580
3.292
0.107
33.173
0.036
0.003
0.056
0.009
0.162
0.004
0.205
0.024
0.979
0.000
LVEF = left ventricular eject fraction, LVEDD = left ventricular end-diastolic dimension, LVESD = left ventricular end-systolic dimension, LVEDV = left ventricular end-diastolic volume, and ESV = left ventricular end-systolic volume. Values are means ± SD. , compared with group A; , compared with group B; , compared with group C; , compared with group D; and , compared with group E.
